These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 29901196)
1. Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway. Zhang H; Hu N Mol Med Rep; 2018 Aug; 18(2):1345-1352. PubMed ID: 29901196 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551 [TBL] [Abstract][Full Text] [Related]
3. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27 Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665 [TBL] [Abstract][Full Text] [Related]
4. Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells. Hua S; Yao M; Vignarajan S; Witting P; Hejazi L; Gong Z; Teng Y; Niknami M; Assinder S; Richardson D; Dong Q Biochim Biophys Acta; 2013 Jun; 1831(6):1146-57. PubMed ID: 23500889 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway. Shang Y; Wang LQ; Guo QY; Shi TL Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Yao LZ; Zhu YL; Liu JJ Technol Cancer Res Treat; 2020; 19():1533033820917959. PubMed ID: 32281513 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑4712‑5p promotes proliferation of the vulvar squamous cell carcinoma cell line A431 by targeting PTEN through the AKT/cyclin D1 signaling pathways. Yang S; Zhao Y; Wang L; Liu C; Lu Y; Fang Z; Shi H; Zhang W; Wu X Oncol Rep; 2019 Nov; 42(5):1689-1698. PubMed ID: 31545465 [TBL] [Abstract][Full Text] [Related]
8. PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway. Xu J; Cai J; Jin X; Yang J; Shen Q; Ding X; Liang Y Oncol Rep; 2015 Sep; 34(3):1424-30. PubMed ID: 26133772 [TBL] [Abstract][Full Text] [Related]
9. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells. Du G; Cao D; Meng L Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑142‑5p modulates breast cancer cell proliferation and apoptosis by targeting phosphatase and tensin homolog. Xu W; Wang W Mol Med Rep; 2018 Jun; 17(6):7529-7536. PubMed ID: 29620260 [TBL] [Abstract][Full Text] [Related]
11. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway. Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway. Hou Z; Quan J Mol Med Rep; 2017 May; 15(5):3285-3291. PubMed ID: 28339072 [TBL] [Abstract][Full Text] [Related]
13. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway. Xu J; Li Z; Su Q; Zhao J; Ma J Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872 [TBL] [Abstract][Full Text] [Related]
14. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Guigon CJ; Zhao L; Willingham MC; Cheng SY Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818 [TBL] [Abstract][Full Text] [Related]
15. [Effects of PTEN over-expression on phosphatidyl inositol 3-kinase/protein kinase B signal pathway in ovarian epithelial cancer cells]. Zhai YN; Xu LL; Shen Y; Xia H; Shen YF Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):682-5. PubMed ID: 21092549 [TBL] [Abstract][Full Text] [Related]
16. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma. Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965 [TBL] [Abstract][Full Text] [Related]
17. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma. Wang H; Chen B; Duan B; Zheng J; Wu X Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834 [TBL] [Abstract][Full Text] [Related]
18. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells. Yang J; Zou Y; Jiang D Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336 [TBL] [Abstract][Full Text] [Related]
19. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas. Nozhat Z; Hedayati M Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586 [TBL] [Abstract][Full Text] [Related]
20. [Rosiglitazone inhibits human HepG2 cell proliferation via PI3K/PTEN/Akt signaling pathway]. Zhang M; Peng L; Qiao Z; He H; Zhou Y; Xu Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):147-50. PubMed ID: 24491054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]